| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$21,681 ) |
| | 2023 | 2019 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01CA200441 | Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infection | 000 | 5 | NIH | 10/17/2022 | -$21,681 |
|
| Issue Date FY: 2022 ( Subtotal = $4,772,275 ) |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 3 | NIH | 1/10/2022 | $109,032 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 6 | NIH | 3/31/2022 | -$50,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 6 | NIH | 3/31/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 6 | NIH | 3/18/2022 | $293,909 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 000 | 3 | NIH | 7/18/2022 | $113,345 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW011921 | African Tuberculosis Bioinformatics Training Program | 000 | 2 | NIH | 3/3/2022 | $108,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 16 | NIH | 6/9/2022 | $172,739 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 16 | NIH | 6/9/2022 | $371,179 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 16 | NIH | 11/19/2021 | $270,182 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 16 | NIH | 11/19/2021 | $580,562 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 001 | 2 | NIH | 8/12/2022 | $400,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD107063 | Understanding ischemia in children with tuberculous meningitis (iThemba) | 000 | 1 | NIH | 8/1/2022 | $463,477 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012302 | Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients | 000 | 1 | NIH | 7/28/2022 | $89,667 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012358 | Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen) | 000 | 1 | NIH | 9/12/2022 | $144,594 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 001 | 1 | NIH | 8/4/2022 | -$30,240 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 001 | 1 | NIH | 8/4/2022 | $30,240 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 1 | NIH | 3/18/2022 | $30,240 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 002 | 2 | NIH | 6/8/2022 | $145,800 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 3 | NIH | 5/19/2022 | $192,287 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 3 | NIH | 5/19/2022 | $142,138 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 3 | NIH | 4/25/2022 | $192,387 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 3 | NIH | 4/25/2022 | $135,784 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 000 | 3 | NIH | 7/6/2022 | $192,500 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 000 | 3 | NIH | 7/6/2022 | $146,404 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136836 | Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | 000 | 5 | NIH | 2/25/2022 | $127,215 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136894 | Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosis | 000 | 4 | NIH | 5/20/2022 | $130,896 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 000 | 5 | NIH | 8/19/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 15 | NIH | 6/6/2022 | $99,254 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 2 | NIH | 2/8/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 001 | 2 | NIH | 7/28/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 000 | 1 | NIH | 5/19/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 001 | 1 | NIH | 2/18/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 000 | 1 | NIH | 10/22/2021 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R61HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 2 | NIH | 5/9/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 002 | 2 | NIH | 8/16/2022 | $141,720 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 002 | 2 | NIH | 8/16/2022 | $157,495 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136837 | Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis | 000 | 3 | NIH | 7/5/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 001 | 5 | NIH | 8/19/2022 | $0 |
| | 2022 | 2020 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010682 | Developing a care bundle for neonatal sepsis prevention in low-resource settings | 000 | 4 | NIH | 4/25/2022 | $0 |
| | 2022 | 2019 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD083042 | Screening for atherosclerotic vascular disease in HIV-infected children | 000 | 5 | NIH | 9/21/2022 | -$654 |
| | 2022 | 2018 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | province | | | ZAF | NU19GH001594 | Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally | 04 | 4 | CDC | 9/30/2022 | -$186,384 |
| | 2022 | 2017 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | province | | | ZAF | NU19GH001594 | Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally | 04 | 4 | CDC | 9/30/2022 | $0 |
| | 2022 | 2017 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01HG008222 | Community Engagement for H3Africa Biobanking Research: The Tygerberg Model | 000 | 3 | NIH | 9/26/2022 | $8,507 |
| | 2022 | 2016 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | province | | | ZAF | NU19GH001594 | Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally | 04 | 4 | CDC | 9/30/2022 | $0 |
| | 2022 | 2015 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | province | | | ZAF | NU19GH001594 | Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally | 04 | 4 | CDC | 9/30/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $5,251,403 ) (Continued on the next page) |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 15 | NIH | 11/18/2020 | $500,871 |
|
